Cargando…
The Contribution of Pharmacogenetic Drug Interactions to 90-Day Hospital Readmissions: Preliminary Results from a Real-World Healthcare System
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines exist for many medications commonly prescribed prior to hospital discharge, yet there are limited data regarding the contribution of gene-x-drug interactions to hospital readmissions. The present study evaluated the relationship b...
Autores principales: | David, Sean P., Singh, Lavisha, Pruitt, Jaclyn, Hensing, Andrew, Hulick, Peter, Meltzer, David O., O’Donnell, Peter H., Dunnenberger, Henry M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705172/ https://www.ncbi.nlm.nih.gov/pubmed/34945714 http://dx.doi.org/10.3390/jpm11121242 |
Ejemplares similares
-
Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System
por: Saulsberry, Loren, et al.
Publicado: (2022) -
Factors Associated With Extended Length of Stay and 90-Day Readmission Rates
Following ACDF
por: Dial, Brian L., et al.
Publicado: (2019) -
Determining the Factors Associated With 30- and 90-day Readmissions Following Plastic Surgery Within the National Readmissions Database
por: Sayegh, Farah, et al.
Publicado: (2020) -
Variant Interpretation in Current Pharmacogenetic Testing
por: Luvsantseren, Sally, et al.
Publicado: (2020) -
Analysis of 90-Day Readmissions After Total Shoulder Arthroplasty
por: Chung, Andrew S., et al.
Publicado: (2019)